According to an informed source, USTR intimated that next week’s ACTA meeting in Washington DC will be attended by all the negotiating parties and that discussions would include all issues under consideration in ACTA. We are still awaiting a response from USTR regarding the attendees, scope and purpose of the meeting but this new information seems to be indicative of nothing short of the next ACTA round.
Earlier, US government officials had informed that the an intersessional meeting would be held the week of 16 August in Washington DC.
Continue Reading →
WHO has released the ‘List of Members of, and Advisor to, the International Health Regulations (2005) Emergency Committee concerning Influenza Pandemic (H1N1) 2009‘ at the following site: http://www.who.int/ihr/emerg_comm_members_2009/en/. Of the 15 members and one advisor, 6 had declaration of interests. On this matter, WHO had the following statement:
Continue Reading →
The following are links to web pages with prices of prescription drugs.
Australia
Schedule Pharmaceutical Benefits
http://www.pbs.gov.au/html/home page
Austria
The Common European Drug Database (CEDD)
http://cedd.oep.hu/
Bahrain
National Health Regulatory Authority
http://www.nhra.bh/SitePages/View.aspx?PageId=42
Belgium
Institut National D’Assurance Maladie-Invalidité Pharmanet
http://www.inami.fgov.be/fr/statistiques/medicament/Pages/statistiques-medicaments-pharmacies-pharmanet.aspx#.WaV_VSeQxQK
Continue Reading →